Zinc salt solutions administered as topical microbicides provided significant protection against herpes simplex virus type 2 infection in a mouse vaginal challenge model. However, at the therapeutic concentration, the salt solutions caused sloughing of sheets of vaginal epithelial cells. These observations limit the utility of zinc salts as microbicides and suggest that the application of zinc solutions to mucosal surfaces has the potential to cause damage that might increase susceptibility to secondary infections at a later time.
The ability of antibody (Ab) to modulate HSV pathogenesis is well recognized but the mechanisms by which HSV-specific IgG antibodies protect against genital HSV-2 disease are not well understood. The requirement for Ab interactions with Fcgamma receptors (FcgammaR) in protection was examined using a murine model of genital HSV-2 infection. IgG antibodies isolated from the serum of HSV-immune mice protected normal mice against HSV-2 disease when administered prior to genital HSV-2 inoculation. However, protection was significantly diminished in recipient mice lacking the gamma chain subunit utilized in FcgammaRI, FcgammaRIII, FcgammaRIV and FcepsilonRI receptors and in normal mice depleted of Gr-1(+) immune cell populations known to express FcgammaR, suggesting protection was largely mediated by an FcgammaR-dependent mechanism. To test whether neutralizing Ab might provide superior protection, a highly neutralizing HSV glycoprotein D (gD)-specific monoclonal antibody (mAb) was utilized. Similar to results with HSV-specific polyclonal IgG, administration of the gD-specific mAb did not prevent initial infection of the genital tract but resulted in lower virus loads in the vaginal epithelium and provided significant protection against disease and acute infection of the sensory ganglia; however, this protection was independent of host FcgammaR expression and was manifest in mice depleted of Gr-1(+) immune cells. Together, these data demonstrate that substantial Ab-mediated protection against genital HSV-2 disease could be achieved by either FcgammaR-dependent or -independent mechanisms. These studies suggest that HSV vaccines might need to elicit multiple, diverse antibody effector mechanisms to achieve optimal protection.
The tissue sites of long-term herpes simplex virus type 2 (HSV-2)-specific antibody production in mice and guinea pigs were identified. In addition to secondary lymphoid tissue and bone marrow, HSV-specific plasma cells were detected in spinal cords of mice up to 10 months after intravaginal inoculation with a thymidine kinase-deficient HSV-2 strain and in lumbosacral ganglia and spinal cords of guinea pigs inoculated with HSV-2 strain MS. The long-term retention of virus-specific plasma cells in the peripheral and central nervous systems following HSV infection may be important for resistance to reinfection of neuronal tissues or may play a role in modulation of reactivation from latency.
Previously, the histidine residue at position 16 in the mature T4 pyrimidine dimer glycosylase (T4-PDG) protein has been suggested to be involved in general (nontarget) DNA binding. This interpretation is likely correct, but, in and of itself, cannot account for the most dramatic phenotype of mutants at this position: their inability to restore ultraviolet light resistance to a DNA repair-deficient Escherichia coli strain. Accordingly, this residue has been mutated to serine, glutamic, aspartic acid, lysine, cysteine, and alanine. The mutant proteins were expressed, purified, and their abilities to carry out several functions of T4-PDG were assessed. The mutant proteins were able to perform most functions tested in vitro, albeit at reduced rates compared with the wild type protein. The most likely explanation for the biochemical phenotypes of the mutants is that the histidine residue is required for rapid turnover of the enzyme. This role is interpreted and discussed in the context of a reaction mechanism able to account for the complete spectrum of products generated by T4-PDG during a single turnover cycle. The base excision repair (BER)1 glycosylases initiate DNA repair by recognizing inappropriate or damaged DNA bases and removing them via glycosyl bond scission (1). These enzymes are responsible for the substrate specificity of their particular BER pathways, a formidable accomplishment, as this recognition must proceed within the context of a vast excess of perfectly normal and appropriate bases. A subset of these enzymes also carry out scission of the DNA sugar-phosphate backbone by -elimination and adjacent to the site of glycosyl bond cleavage. These enzymes will be referred to as "BER glycosylase-lyases." Enzymes in this subset of glycosylases utilize a primary or secondary amino group as an active site nucleophile. The amino group adds to C 1 Ј because of the developing electrophilic character of that carbon accompanying glycosyl bond cleavage. The resulting Schiff base enzyme-DNA intermediate, in its protonated form, has been proposed to kinetically assist DNA backbone cleavage (2). Gerlt (3) has hypothesized that the rate of the -elimination reaction is directly determined by the acidity of the 2Ј-hydrogens on the sugar undergoing 3Ј-phosphate group elimination. Within this hypothesis, the role of the protonated Schiff base would be to lower the pK a of the 2Ј-hydrogens. In the proposed reaction scheme, one of these hydrogens would be abstracted by a general base, either an activated water or a basic amino acid side chain. T4-PDG is a ultraviolet light (UV) pyrimidine photodimer-specific BER glycosylase-lyase similar mechanistically to other BER glycosylase-lyases. The N-terminal threonine ␣-amino group is the active site nucleophile (4).To investigate those amino acid candidates whose side chains might serve as general bases for abstracting a sugar 2Ј-hydrogen to initiate the -elimination reaction, we identified all amino acid side chains within 10 Å of the ␣-amino nitrogen in the cocrystal struc...
The requirement for Ab -Fcγ receptor (FcγR) interactions or for virus neutralization in protection against genital HSV-2 challenge was examined. Serum IgG Ab isolated from HSV-immune mice protected normal mice against HSV-2 disease when administered prior to challenge. However, protection was significantly diminished in mice lacking the γ chain subunit utilized in FcγRI, FcγRIII, FcγRIV, and FcεRI and in normal mice depleted of FcγR+, Gr-1+ immune cells suggesting protection was largely mediated by an FcγR-dependent mechanism. To test if FcγR-independent antibody-mediated mechanisms might manifest protection differently, a highly neutralizing, HSV glycoprotein D -specific monoclonal antibody (mAb) was utilized. Administration of IgG1, IgG2a, or IgG2b switch variants of the mAb did not prevent infection of the genital tract but resulted in lower virus loads in the vaginal epithelium and provided significant protection against disease and acute infection of the sensory ganglia independently of host FcγR expression. Together, these data demonstrate two distinct antibody effector mechanisms capable of providing substantial protection against genital HSV-2 disease. The presence of either FcγR -dependent Ab or strongly neutralizing Ab did not completely prevent HSV-2 infection but limited initial infection of genital and neuronal tissues and diminished HSV-2 disease. NIH Grants AI42815 and AI054444.
In recent years, significant progress has been made in determining the catalytic mechanisms by which base excision repair (BER) DNA glycosylases and glycosylase-abasic site (AP) lyases cleave the glycosyl bond. While these investigations have identified active site residues and active site architectures, few investigations have analyzed post-incision turnover events. Previously, we identified a critical residue (His16) in the T4 pyrimidine dimer glycosylase (T4-Pdg) that when mutated, interferes with enzyme turnover [Meador et al. (2004) J Biol Chem 279, 3348-3353]. To test whether comparable residues and mechanisms might be operative for other BER glycosylase-AP lyases, molecular modeling studies were conducted comparing the active site regions of T4-Pdg and the Escherichia coli formamidopyrimidine DNA glycosylase (Fpg). These analyses revealed that His71 in Fpg might perform a similar function to His16 in T4-Pdg. Site-directed mutagenesis of the Fpg gene and analyses of the reaction mechanism of the mutant enzyme revealed that the H71A enzyme retained activity on a DNA substrate containing an 8-oxo-7,8-dihydroguanine (8-oxoG) opposite cytosine and DNA containing an AP site. The H71A Fpg mutant was severely compromised in enzyme turnover on the 8-oxoG-C substrate, but had turnover rates comparable to wild-type Fpg on AP-containing DNA. The similar mutant phenotypes for these two enzymes, despite a complete lack of structural or sequence homology between them, suggest a common mechanism for the rate limiting step catalyzed by BER glycosylase-AP lyases.Prokaryotic and eukaryotic cells utilize a number of different mechanisms to repair constantly accumulating DNA damage due to environmental and endogenous chemical agents. In the absence of repair, many DNA lesions may block replication and transcription, while others may decrease replication fidelity. These disruptions may result in mutations and ultimately carcinogenesis in eukaryotes. The base excision repair (BER)1 pathway is a key component in the cellular response to DNA lesions (1). Formamidopyrimidine DNA glycosylase (Fpg) functions in the E. coli BER pathway as an N-glycosylase and abasic site (AP) lyase, with the predominant DNA incision product resulting from a δ-elimination reaction (2). The Fpg glycosylase activity results in the removal of formamidopyrimidine (Fapy) or 8-oxo-7,8-dihydroguanine (8-oxoG) lesions (3, 4). The catalytic mechanism of † This work was supported by National Institutes of Health Grant, ES04091.* To whom correspondence should be addressed: 3181 SW Sam Jackson Park Rd., L606, Portland, ; AP, apurinic; BER, base excision repair; DTT, dithiothreitol; Fapy, formamidopyrimidine; Fpg, formamidopyrimidine DNA glycosylase; T4-Pdg, T4-pyrimidine dimer glycosylase; EDTA, ethylenediaminetetraacetic acid; PMSF, phenylmethylsulphonylfluoride; HEPES, N-(2-hydroxyethyl)-piperazine-N'-2-ethanesulfonic acid. NIH Public Access Author ManuscriptBiochemistry. Author manuscript; available in PMC 2011 September 27. Fpg is similar to that o...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.